A Pilot Study of Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients Who Can Tolerate Aggressive Therapy.
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2015
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 29 Oct 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 11 Apr 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 22 Jan 2013 Planned end date changed from 1 Dec 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.